Companies
- Companies
- Company details
Angiogene
Bridging the gap between Drug and DeviceThe company in detail
Summary
Located in Montreal, Canada, Angiogene is a venture-backed, private biotechnology company, dedicated to the development of radiology-based products for the treatment of cardio and cerebro-vascular diseases.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 21 pages - $500
Dec 2010 - 56 pages - $500
Sep 2011 - 612 pages - $500
Jan 2011 - 289 pages - $500
Jul 2007 - 270 pages - $3,400
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Human therapeutics
- Medical device / Therapeutic device
- Medical device / Therapeutic medical equipment / Surgical products
- Service / Research
- Therapeutic target
- Cardiovascular
- Cardiovascular / Acute coronary syndromes / Angina
- Cardiovascular / Acute coronary syndromes / Congestive heart failure
- Cardiovascular / Acute coronary syndromes / Myocardial infarction
- Cardiovascular / Cardiovascular disorder (other) / Restenosis
- Central Nervous System
- Central Nervous System / Neurological / Cerebrovascular disorders
- Oncology
- Oncology / Cancer (other)
- Oncology / Lung cancer
- Oncology / Treatments / Radiotherapy
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us